Sequential immunoprecipitates show that H-
One informative approach to defining structure-function relationships for major histocompatibility complex (MHC) class I antigens has been to characterize several naturally occurring mutants of these molecules (1, 2). The mutations in murine H-2 antigens are generally found to be of two basic types-those in which the primary amino acid sequence of an H-2 antigen has changed and those in which the expression of H-2 antigens has been altered or lost. For example, most of the "bm" mutants (e.g., bml, etc.) of the b haplotype show various amino acid substitutions in the H-2Kb antigen (3) as a consequence of changes in small segments of the MHC H-2K gene DNA sequence, perhaps occurring through some type of gene conversion event (4, 5) . However, several other mutations, particularly those affecting H-2 antigens derived from the H-2D/L genes of the MHC, appear to show complete or partial losses in the expression of at least one antigen-the H-2Ld antigen in the dm2 mutation (6, 7) ; the H-2D antigen in the dm6 mutation (8) ; and the H2Dlb antigen in the bml3 mutation (9) .
At least one H-2 antigen mutant, the dml mutant (10) , clearly has a different phenotype than those described above. This mutant involves more than one H-2 antigen, and both basic types of alterations discussed above appear to be in effect. Specifically, histogenetic, serological and structural analyses of the dm1 mutant indicate that major alterations in the structures and/or the expression of at least three H-2D/L-linked antigens are affected in this mutant (6, (11) (12) (13) (14) (15) (16) . Although the phenotype of this mutant is quite complex, most of its properties can be accounted for by two relatively simple observations: separate molecular allomorphs of the parental H-2Dd and H-2Ld antigens do not appear to be expressed in dm1 mutant cells (unpublished observation), whereas one molecule with a combination of structural properties of these two antigens does appear to be expressed (14) .
This "hybrid" molecule, here designated the H-2D/Ldml antigen, is further characterized in the present study by using monoclonal antibodies (mAbs) and cytotoxic T lymphocytes (CTL), both directed against structurally defined determinants or regions of the parental H-2Dd and H-2Ld antigens.
MATERIALS AND METHODS
Mice. All mice came from breeding colonies described previously (14, 17) (18, 19) of four mAbs used in this study and the H-2 antigen domain specificities (20) (14) .
Immunoprecipitation Reactions and NaDodSO4/PAGE.
With the following inclusions, the procedures for direct sequential antibody precipitates, using heat-killed Staphylococcus aureus, and for analysis of NaDodSO4/PAGE (including counting procedures) have been described (22) . In this study, rabbit anti-mouse IgG (together with S. aureus) was used to optimize mAb precipitation efficiencies. For the discontinuous, NaDodSO4/PAGE of 2-mercaptoethanol-reduced samples, 10-cm cylindrical resolving gels were made with 13% (wt/vol) acrylamide. The radioactive profiles shown in Figs. 1 and 2 are only for the 1.0-to 8.5-cm portion of the respective gels, because no radioactivity above background levels was detected outside this region.
CTL and Unlabeled-Target Inhibition Analysis. These procedures have been detailed (17) . 2.4 alloantiserum used in Fig. 1 were sequentially reacted with dm1 mutant or d parent glycoprotein extracts to ascertain which of the antibody-defined determinants co-exist on the same molecule. In such experiments, equal aliquots of dm1 or d glycoprotein extract reacted 3 times in sequence with different combinations of antibodies, and the resulting sequential immunoprecipitates were analyzed by NaDod-S04/PAGE. Fig. 2 shows representative results of several triple sequential immunoprecipitate reactions carried out in this study. Here, the NaDodSO4/PAGE profiles of the antigen immunoprecipitated in the third (or "test") step of a sequence are illustrated. Fig. 2 A-D shows the relative amounts of anti-H-2.4-reactive dm1 glycoprotein that remained after treatment (2 times) with 30.5.7 ( Fig. 2A) , 28.14.8 ( Fig. 2B ), a combination of these two mAbs (Fig.  2C) , or the irrelevant anti-H-2Kb mAb, SF1.2 (Fig. 2D) . In samples treated with either H-2Ld-specific mAb, the level of anti-H-2.4-reactive antigen was significantly decreased (73% and 88% decrease in Fig. 2 A and B, respectively) as compared to the control sample (Fig. 2D ). Although neither of the H-2Ld-specific mAbs alone was effective in completely precipitating the anti-H-2.4-reactive antigen in dm1 extracts, a combination of the two mAbs virtually eliminated all anti-H-2.4-reactive antigen (Fig. 2C ).
[It was generally difficult to find conditions in which individual mAbs could completely precipitate their target antigens, even from d extracts (data not shown) and even when a second anti-IgG antibody was used in conjunction with S. aureus and the mAb. However, in keeping with findings by others (24), combinations of different mAbs were usually more effective in precipitating antigen.] It is concluded that a single molecular species in dm1 mutant extracts bears H-2Ld as well as H-2Dd determinants.
Several other triple sequential immunoprecipitates of dm1 antigens using reciprocal combinations of the same antibodies gave similar results to those just described. Summarizing these data (not shown), the 30.5.7 and 34.5.8 mAbs and the anti-H-2.4 alloantiserum all reciprocally react with the same molecules in dm1 extracts, as determined by the finding that two successive reactions with any one of these antibodies significantly decreased the level of antigen (>80% decrease) detected by any other one of these antibodies. Also, the 28.14.8 mAb virtually eliminated all dm1 antigens reactive with any one of the other three antibodies above. Thus, it is concluded that dml cells express a molecule that bears all of the determinants defined by the 30.5.7, 34.5.8, and 28.14.8 mAbs and by the anti-H-2.4 alloantiserum.
These results with dm1 mutant antigens contrast those obtained with radiolabeled glycoprotein antigens of the d parental haplotype. Two successive immunoprecipitates of d extract aliquots with 30.5.7 (Fig. 2E) , 28.14.8 (Fig. 2F) , or a combination of these two mAbs (Fig. 2G) had no significant effect on the normal level of the H-2Dd antigen, as determined after two successive reactions with SF1.2 (Fig. 2H) . (In these experiments, the H-2Dd antigen was immunoprecipitated using a combination of mAbs 34.5.8 and 34.2.12, which together reacted with all anti-H-2.4-reactive material in d extracts as found in other experiments; data not shown.) A quantitative difference between the amounts of anti-H-2.4-reactive glycoprotein in d as compared to dm1 extracts (cf. Fig. 2 D and H) has now been observed in several experiments.
Recognition of dm1 Antigens by Anti-H-2Ld-and Anti-H2Dd-Specific CTL. The H-2 antigens expressed by dm1 cells were further characterized by their effectiveness in inhibiting the action of CTL specific for determinants of the parental H-2Ld and H-2Dd antigens. Fig. 3 shows representative results of several unlabeled-target inhibition studies, in which unlabeled concanavalin A blasts of splenocytes from mice of various haplotypes were titrated for their ability to inhibit the lysis of 5tCr-labeled targets by CTL of various specificities. Fig. 3A shows the inhibition patterns obtained when b haplotype CTL educated against a stimulator cells are cross-tested on bml targets. As previously shown and discussed (17), the strong cross-reaction by b anti-a CTL on bml targets is mediated primarily by the b anti-H-2Ld CTL subpopulation, which detects shared structural determinants created by the uni~uely homologous stretch of amino acid sequence in H-2L and H-2Kbml, including Ala152-Tyr'55-Tyr156. As Fig. 3A shows, dm1 cells significantly inhibit this cross-reactive lysis of bml targets, although the degree of inhibition is less than that found for the homologous combinations using cells of the a or d (B1O.D2) haplotypes. As expected, dm2 cells that completely lack expression of the H-2Ld antigen (8) inhibit only at the nonspecific background levels of b inhibitors, the effector cell haplotype. It is concluded from this experiment that dm1 cells express H-2 antigens having at least partial amino acid sequence homology to the H-2Ld antigen in the region spanning residues 152-156.
In spite of the fact that dm1 cells do appear to express certain H-2Ld-related determinants, other such determinants appear to be completely lacking in mutant cells, as shown in Fig. 3B . Here, cells of various haplotypes were tested for their abilities to inhibit d haplotype target cell lysis by dm2 anti-d (i.e., dm2 anti-H-2Ld) CTL. In contrast to parental type d cells, dm1 cells are no better than effector haplotype dm2 cells at inhibiting dm2 target lysis. Thus, it is concluded that dm1 mutant cells appear to have completely lost (or only weakly express) determinants associated with the H-2Ld antigen, as recognized by alloreactive anti-H-2Ld CTL.
In the final inhibition analysis (Fig. 3C ), dm1 cells were tested for their ability to inhibit the k anti-H-2Dd subpopulation of k anti-a CTL tested on dm2 targets. (The first 5'-exon, L, encodes a leader sequence.) Because all three of the antigens have similar molecular weights (as determined by NaDodSO4 gel electrophoresis), the mutant antigen is also likely to be organized into three extracellular domains of comparable size. As suggested by its white and black structural segments in Fig. 4 , the mutant antigen appears to be a structural mosaic of the two parental antigen structures, because it is found to share a number of properties with each. The shared properties, as indicated by the symbols located between adjacent structures in this figure, are summarized in the following paragraph. As proposed previously (14) , the NH2-terminal extracellular portion of the H-2D/Ldml antigen (white structural segment of this molecule in Fig. 4 ) is likely to derive from the corresponding region of the H-2Dd antigen. Such appears to be the case because the arginine-containing tryptic peptides of these two molecules are almost identical (12, 14) , in contrast to the lysine-containing tryptic peptides. Fig. 4 ) appears to derive from the corresponding region of H-2Ld. In addition to the fact that there is significant structural homology between these two molecules, as indicated by their nearly identical lysine-containing tryptic peptides (14) , the mutant antigen cross-reacts ( Fig. 1E) with the anti-H-2Ld(C2)-specific mAb and not (Fig. 1B) As demonstrated by sequential precipitation analysis in the present study (Fig. 2 A-D Immunology: Burnside et aLP to react with more than one antigen-for example, it consistently yielded larger immunoprecipitates as compared to 30.5.7 (cf. Fig. 1 C and E) , and its target antigen in dm1 extracts could not be completely cleared by any of the other antibodies (data not shown)-the structural studies, as noted above, indicate that 28.14.8 may react with only one antigen with a distinct amino acid sequence. Thus, the immunoprecipitation differences between the various mAbs are probably explained by the inefficiency that mAbs generally show in immunoprecipitation reactions when used individually. In any case, only one conventionally defined H-2D/Lrelated glycoprotein has been clearly identified for dm1 mutant cells, and other such antigens, if they exist, are likely to be relatively minor species or highly homologous in structure to H-2D/Ldml
Because an H-2Dd/H-2Ld structural discontinuity probably exists within the C1 domain of the hybrid antigen on the COOH-terminal side of residue 131 and on the NH2-terminal side of residue 152 (dotted region of H-2D/Ldml), it is proposed that the mutant antigen originates from a hemoglobin Lepore-like hybrid gene (35, 36) rather than from an RNA splicing abnormality. The latter possibility would more likely affect structures in or near the domain boundaries, which are determined by exon/intron splicing patterns. In any event, the dm1 mutant is phenotypically like all other mutants involving H-2D/L-related gene products (as discussed in the Introduction), because it also exhibits a major deletion of genetic information normally expressed in the parent haplotype. Unequal recombination between the genes for MHC antigens may be an important mechanism for generating H-2 antigen polymorphism.
